Morningstar Investor users sign in here.

Company Profile

  • Business description

    Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2023, approximately one third of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first US approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

  • Contact

    3-5-1, Nihonbashi-honcho
    Chuo-ku
    Tokyo 103-8426
    JPN

    T: +81 362251111

    https://www.daiichisankyo.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2025

    Employees

    17,435

Stocks News & Analysis

stocks

The secrets of Australia’s Berkshire Hathaway

Washington H. Soul Pattinson is an ASX top 50 stock with one of the best investment track records this country has seen. Yet, most Australians haven’t heard of it, and the company seems to prefer it that way.
stocks

Have some of the ASX 200's worst performers fallen too far?

These four stocks have had an awful twelve months. Morningstar's analysts weigh in on whether they offer good value yet. 
stocks

Private equity bid dramatically undervalues ASX listed share

We believe the bid is an attempt to capitalise on share price weakness. 

Markets

Index
Last price
Change
% Change
All Ordinaries 7,960.50 45.40 -0.57%
CAC 40 7,789.21 104.77 -1.33%
DAX 40 18,369.94 124.95 -0.68%
Dow JONES (US) 38,747.42 120.62 -0.31%
FTSE 100 8,147.81 80.67 -0.98%
HKSE 17,962.06 214.28 -1.18%
NASDAQ 17,343.55 151.02 0.88%
Nikkei 225 38,826.33 308.46 -0.79%
NZX 50 Index 11,806.76 21.28 0.18%
S&P 500 5,375.32 14.53 0.27%
S&P/ASX 200 7,712.80 42.60 -0.55%
SSE Composite Index 3,026.71 1.34 -0.04%

Market Movers

Name
Last price
Change
% Change
Judo Capital Holdings Ltd JDO 1.40 0.10 7.31%
Core Lithium Ltd CXO 0.09 0.01 -6.00%
Northern Minerals Ltd NTU 0.04 0.01 -16.28%
Sayona Mining Ltd SYA 0.04 0.00 4.05%
South32 Ltd S32 3.66 0.02 -0.41%
Nickel Industries Ltd NIC 0.87 0.05 -5.16%
Pilbara Minerals Ltd PLS 3.46 0.06 -1.57%
Zip Co Ltd ZIP 1.29 0.00 0.19%
Melbana Energy Ltd MAY 0.07 0.00 -4.05%
Mirvac Group MGR 1.90 0.01 0.66%